Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/1

Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/1 is a combination medication used in the treatment of HIV infection. This oral tablet helps manage the virus and supports immune system health.

Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/1 is primarily used as part of antiretroviral therapy to treat HIV infection. This combination medication works by reducing the amount of HIV in the body, helping to control the progression of the disease. It is often prescribed to adults and adolescents as part of a comprehensive treatment plan.

Common effects of Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/1 may include dizziness, nausea, and headache. Some individuals might experience changes in dreams or rash. These effects can vary and are not exhaustive; consult a healthcare provider for personalized advice.

Handle Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/1 with care, following the prescribed dosage and instructions. Avoid alcohol and other medications that may interact negatively. Store the tablets in a cool, dry place away from direct sunlight.

Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/1 may interact with other medications, including those metabolized by the liver's cytochrome P450 system. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.